BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19479864)

  • 1. Cellular immunity in Wegener's granulomatosis: characterizing T lymphocytes.
    Berden AE; Kallenberg CG; Savage CO; Yard BA; Abdulahad WH; de Heer E; Bruijn JA; Bajema IM
    Arthritis Rheum; 2009 Jun; 60(6):1578-87. PubMed ID: 19479864
    [No Abstract]   [Full Text] [Related]  

  • 2. T cell alterations and lymphoid neogenesis favoring autoimmunity in Wegener's granulomatosis.
    Lamprecht P; Gross WL; Kabelitz D
    Arthritis Rheum; 2007 Jun; 56(6):1725-7. PubMed ID: 17530695
    [No Abstract]   [Full Text] [Related]  

  • 3. Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases.
    Rondaan C; de Haan A; Horst G; Hempel JC; van Leer C; Bos NA; van Assen S; Bijl M; Westra J
    Arthritis Rheumatol; 2014 Nov; 66(11):3122-8. PubMed ID: 25223407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excessive interleukin-15 transpresentation endows NKG2D+CD4+ T cells with innate-like capacity to lyse vascular endothelium in granulomatosis with polyangiitis (Wegener's).
    de Menthon M; Lambert M; Guiard E; Tognarelli S; Bienvenu B; Karras A; Guillevin L; Caillat-Zucman S
    Arthritis Rheum; 2011 Jul; 63(7):2116-26. PubMed ID: 21484763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Wegener's granulomatosis with anti-neutrophil cytoplasmic antibodies against anti-cathepsin G antigen].
    Ocaña Pérez E; Peña Casas AM; del Campo Muñoz T; Avila Casas A; Luque Barona R
    An Pediatr (Barc); 2013 Dec; 79(6):381-4. PubMed ID: 23602835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible implication of the effector CD4+ T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma.
    Deleuran B; Abraham DJ
    Nat Clin Pract Rheumatol; 2007 Dec; 3(12):682-3. PubMed ID: 17848933
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytoplasmic-anti-neutrophil cytoplasmic antibodies targeting myeloperoxidase in Wegener's granulomatosis: a rare phenomenon.
    Venkatesh BM; Joshi S; Adhikary R
    Indian J Pathol Microbiol; 2014; 57(3):470-2. PubMed ID: 25118749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis.
    Wiik A
    Clin Exp Rheumatol; 1993; 11(2):191-201. PubMed ID: 8508563
    [No Abstract]   [Full Text] [Related]  

  • 9. Advances in pathogenesis and treatment of ANCA-associated vasculitis.
    Kallenberg CG
    Discov Med; 2014 Oct; 18(99):195-201. PubMed ID: 25336033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Wegener's granulomatosis].
    Cottin V; Khouatra C; Chalabreysse L; Cordier JF
    Rev Prat; 2006 Jan; 56(2):129. PubMed ID: 16584037
    [No Abstract]   [Full Text] [Related]  

  • 11. Update in ophthalmic and general pathology: Wegener's granulomatosis--a review of the ophthalmic manifestations.
    Heathcote JG
    Can J Ophthalmol; 1997 Apr; 32(3):149-52. PubMed ID: 9131276
    [No Abstract]   [Full Text] [Related]  

  • 12. Antineutrophil cytoplasmic antibodies.
    Bosch X; Guilabert A; Font J
    Lancet; 2006 Jul; 368(9533):404-18. PubMed ID: 16876669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effector memory T cells as driving force of granuloma formation and autoimmunity in Wegener's granulomatosis.
    Lamprecht P; Csernok E; Gross WL
    J Intern Med; 2006 Sep; 260(3):187-91. PubMed ID: 16918816
    [No Abstract]   [Full Text] [Related]  

  • 14. Wegener's granulomatosis.
    Sneller MC
    JAMA; 1995 Apr; 273(16):1288-91. PubMed ID: 7715042
    [No Abstract]   [Full Text] [Related]  

  • 15. Wegener's granulomatosis and rheumatoid arthritis overlap.
    Chinoy H; McKenna F
    Rheumatology (Oxford); 2002 May; 41(5):588-9. PubMed ID: 12011387
    [No Abstract]   [Full Text] [Related]  

  • 16. Wegener's granulomatosis: ischemic stroke as the first clinical manifestation (case study).
    Bares M; Muchová M; Dufek M; Litzman J; Krupa P; Rektor I
    J Neurol; 2002 Nov; 249(11):1593-4. PubMed ID: 12532922
    [No Abstract]   [Full Text] [Related]  

  • 17. Wegener's granulomatosis.
    Slot MC; Tervaert JW
    Autoimmunity; 2004 Jun; 37(4):313-5. PubMed ID: 15518049
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tracheobronchial involvement in Wegener's granulomatosis].
    Solans Laque R; Lorente J; Canela M
    Med Clin (Barc); 2011 Jul; 137(5):230-5. PubMed ID: 21450317
    [No Abstract]   [Full Text] [Related]  

  • 19. New perspectives in Wegener's granulomatosis.
    Dreisin RB
    Thorax; 1993 Feb; 48(2):97-9. PubMed ID: 8493642
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevated initial serum creatinine in Wegener's granulomatosis with anti-myeloperoxidase autoantibodies.
    Lai MY; Lin CC; Ng YY; Yang WC
    Kidney Int; 2006 Apr; 69(7):1281. PubMed ID: 16609690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.